Psilocybin Interactions: The Medications That Matter
Psilocybin is physiologically gentle, but a few interactions matter a great deal - one (lithium) is a serious seizure risk. A clear guide to antidepressants, lithium, tramadol, and common combinations.
Psilocybin is, physiologically, one of the gentler psychoactive substances - but "gentle" doesn't mean "no interactions." A few combinations genuinely matter, and one of them is a serious seizure risk that surprises people. This is a clear, prioritised guide.
Read this first.
Threshold does not sell, supply, or encourage drug use. The lowest-risk option is not to use. This is educational, not medical advice. If you take any prescription medication, talk to a doctor or pharmacist before combining anything.
The one to take most seriously: lithium
Afterglow
Of everything we tried for the comedown, this is the one that made a real difference to how we slept and how flat Tuesday felt. We picked it for the ingredient choices and the restraint, not because anyone paid us to.
Read the full review →Lithium combined with psilocybin (and other classic psychedelics) has been associated with seizures and serious adverse events. This is widely treated in harm-reduction sources as a combination to avoid outright. If you are prescribed lithium, do not combine it with psychedelics - and changing a lithium prescription is a decision for your prescriber, not something to do on your own.
Antidepressants: mostly blunting, with nuance
- SSRIs and SNRIs (e.g. sertraline, escitalopram, venlafaxine) typically reduce psilocybin's effects, because chronic use down-regulates the serotonin 2A receptors psilocybin works through. The practical risks are (a) disappointment leading to redosing, and (b) the false assumption that "nothing happens, so it's safe."
- MAOIs and the plant-based MAOI harmala can intensify and prolong psilocybin substantially, and add their own interaction risks. Treat any MAOI combination as something to avoid unless under expert guidance.
- Tricyclics and lithium behave differently again - lithium especially (see above).
Stopping a prescribed antidepressant to "make the mushrooms work" carries its own risks (discontinuation effects, plus the reason it was prescribed). That is a conversation with the prescribing doctor - not a DIY taper.
Tramadol and other serotonergic drugs
Tramadol is both serotonergic and lowers the seizure threshold; combining it with psychedelics is best avoided. More broadly, stacking psilocybin with other strongly serotonergic drugs raises the theoretical risk of serotonin-type effects - be conservative.
Cannabis
Very commonly combined, and lower-risk physically - but worth flagging: cannabis can intensify and destabilise a psilocybin experience, sometimes turning a manageable moment into an anxious or confusing one, especially at higher cannabis doses or during the come-up and comedown. If you're new to mushrooms, it's wise to leave cannabis out of the first few experiences so you know your baseline.
Stimulants and alcohol
- Stimulants (amphetamine, cocaine, caffeine in quantity) add anxiety and physical load and pull against the introspective character of the experience.
- Alcohol dulls and muddies the experience and adds dehydration; most people find it works against what they came for.
A note on the body
Beyond drug interactions, the standard medical contraindications still apply: a personal or family history of psychosis or bipolar disorder, certain heart conditions, and pregnancy. See set and setting for the psychological side.
The short version
The headline is lithium - avoid it with psychedelics (seizure risk). MAOIs intensify and complicate; SSRIs/SNRIs mostly blunt and tempt redosing; tramadol and other serotonergic drugs are best avoided; cannabis can destabilise the experience. For any prescription, assume an interaction until a pharmacist or doctor tells you otherwise.
Educational only, not medical advice. The lithium-psychedelic combination is a documented seizure risk; never combine them, and never alter prescribed medication without your doctor.
Sources
- Halman A, et al. Drug-drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol. 2024.
- Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008.
- TripSit drug combination guidance. tripsit.me.